Diode laser as an additional therapeutic measure in reducing red complex bacteria in chronic periodontitis by Mulder-Van Staden, Sune
 
DIODE LASER AS AN ADDITIONAL THERAPEUTIC 
MEASURE IN REDUCING RED COMPLEX 
BACTERIA IN CHRONIC PERIODONTITIS. 
 
 
 
 
Suné Mulder-van Staden 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A mini-thesis submitted in partial fulfilment of the requirements 
for the degree of MChD in Oral Medicine and Periodontology, 
University of the Western Cape 
 
 
 
 
 
 
 
 
 
 
 
Supervisor: Dr 
H. Holmes  
Co-supervisor: 
Prof J. Hille 
 
 
 
2016 
 
 
 
 
i  
 
DIODE LASER AS AN ADDITIONAL THERAPEUTIC MEASURE IN 
REDUCING RED COMPLEX BACTERIA IN CHRONIC 
PERIODONTITIS. 
 
 
 
 
 
Suné Mulder-van Staden 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KEYWORDS 
 
 
 
Chronic periodontitis 
Periodontal clinical parameters 
Red complex bacteria 
Conventional management of periodontal diseases (i.e. scaling, root planing 
and polishing) 
 
Bacterial collection 
 
 
 
Polymerase chain reaction (PCR) 
Diode laser (810 ± 10nm) 
 
 
 
 
ii  
 
ABSTRACT 
 
 
 
DIODE LASER AS AN ADDITIONAL THERAPEUTIC MEASURE IN 
REDUCING RED COMPLEX BACTERIA IN CHRONIC 
PERIODONTITIS. 
 
Suné Mulder-van Staden 
 
 
MChD (Oral Medicine & Periodontics), Department of Oral Medicine and 
Periodontology, University of the Western Cape. 
 
 
 
 
 
This mini-thesis assessed whether a diode laser with a wavelength of 810 ± 
10nm can be utilized as an adjunct to conventional management (i.e. scaling, 
root planing and polishing) of chronic periodontitis during initial phase therapy. 
 
Ethical approval and study registration (Reg no: 14/9/6) was finalized prior to 
commencement of the study. A split mouth randomised control trial was 
performed on 25 participants (who presented at the Oral Medicine and 
Periodontology Department of the University of the Western Cape) diagnosed 
with active, chronic periodontitis. In order to standardise the split mouth design 
the quadrants 1 & 4 were assessed together as a set and quadrants 2 & 3 
were assessed as a set. A set of these quadrants were randomly assigned to 
either the test or control quadrants after conventional management was 
performed in all four quadrants. The base line bacterial colony collection 
(Micro-IDent®-11, Hain Lifescience GmbH, Nehren, Germany) and the 
clinical parameters were assessed prior to the commencement of 
conventional management and were reassessed at the 6 week re-evaluation 
visit. 
 
The set of test quadrants were treated with the diode laser as an adjunct to the 
preceding conventional management. The control quadrant only received the 
conventional management. 
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Evaluation of the results demonstrated that the diode laser produced no 
statistical decrease in the bacterial parameters in the periodontal pockets and 
resulted in a statistical increase of C. showae (Cs) and T. denticola (Td). The 
clinical parameters resulted in no statistical difference for any clinical 
parameter, with the exception of the reduction in BOP that was statistically 
significant (p< 0,05) with the laser as an adjunct. 
 
It is the recommendation that within the limitations of this study, that the 
utilization of the diode laser (810 ± 10nm) as an adjunct at the initial visit had 
no statistical effect in the reduction of the bacterial parameters nor resulted in 
an overall improvement of the clinical parameters. 
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CHAPTER 1: INTRODUCTION 
 
 
1.1. Periodontitis and the bacterial flora 
 
 
The healthy oral cavity harbours a vast number of micro-organisms which exist in a 
homeostatic equilibrium. However, under certain conditions (such as excessive plaque 
accumulation; immunosuppression, hormonal imbalances to name a few) a pathogenic subset 
of these micro-organisms may overgrow, resulting in the development of periodontal tissue 
destruction and disease (Lindhe, 2015:385). 
 
Periodontitis is a multifactorial disease affecting most populations worldwide with tissue 
destruction and disease progression occurring as a result of complex interactions between 
micro-organisms, environmental factors and the host tissues (Holt, 2006; Cheng, 2016). 
 
Chronic periodontitis is defined as inflammation of the gingiva extending into the adjacent 
attachment apparatus. The disease is characterized by a loss of clinical attachment due to the 
destruction of the periodontal ligament and supporting alveolar bone (Parameters of Care – 
American Academy of Periodontology, 2000).  
 
 
Periodontitis arises from a consortium of micro-organisms, with some micro-organisms 
demonstrating a more significant role than others as aetiologic agents (Nishihara, 2004; 
Lindhe, 2016:385). 
 
The micro-organisms responsible for the destruction of periodontal tissues reside in biofilms, 
which colonizes the tooth surface and the periodontal pocket (Socransky, 2002). Periodontal 
tissue destruction is triggered by the formation of these complex biofilms (Holt, 2005), whose 
function is to provide protection for resident micro-organisms. This biofilm offers effective 
protection from competing micro-organisms, host defence mechanisms and potentially 
toxic substances (such as antimicrobials) in the oral cavity (Socransky, 2002; Marsh, 2011). 
 
Socransky (1998) performed studies to define the bacterial communities that resided in the 
subgingival plaque. These communities were classified into five complexes and were 
assigned colours – namely red, orange, green, yellow and purple, which defined the different 
stages of bacterial colonization on the tooth surface, degree of disease severity and 
progression (Socransky, 1998). 
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Figure 1. Diagram of the relationships of species within microbial complexes and between 
the microbial complexes (Socransky, 1998). 
 
 
 
 
 
During the transition from health to periodontal disease, a shift occurs in the type of resident 
micro-organisms present in the periodontal pocket (Marsh, 2011). Initial colonization of the 
tooth surface involves the yellow, green and purple complexes, which includes the blue 
Actinomyces species (Socransky, 1998). As the development of periodontal disease 
progresses, the orange and red complexes gradually increase in number and become the 
predominant species (Socransky, 2005). 
 
Cultivation of plaque micro-organisms from chronic and aggressive periodontitis sites reveals 
high percentages of anaerobic and gram negative bacterial species (Lindhe, 2015:410). The 
bacteria most predominantly found include Porphyromonas gingivalis (P.g), Tanerella 
forsythia (T.f), Prevotella intermedia (P.i), Camphylobacter rectus (C.r), Eikenella 
corrodens (E.c), Fusobacterium nucleatum (F.n), Aggregatibacter actinomycetemcomitans 
(A.a), Treponema species and Eubacterium species. High levels of P.g, P.i, T.f, C.r and 
A.a are associated with disease progression. Both P.g and
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A.a are known to invade host tissue cells, which is a significant factor in aggressive forms of 
periodontitis (Darveau, 1997. Lindhe, 2015:209). 
 
The red complex bacteria (described by Socransky, 1998) (Figure 1) have been 
demonstrated to be the predominant microbial species involved in periodontal disease 
progression and significant periodontal tissue destruction. These red complex bacteria include 
P. g, T.d and T.f (Socransky, 1998). 
 
The red complex bacteria which appear in the later stages of biofilm development are 
associated with periodontal disease deeper periodontal probing depths and bleeding on 
probing (Socransky, 1998. Socransky, 2005). These bacteria possess numerous virulence 
factors, such as the ability to invade the host epithelial and vascular endothelial cells 
(Socransky, 1998). 
 
 
 
 
 
1.2. Role of periodontal pathogens in the development of systemic diseases 
 
 
The potential role of periodontal pathogens in the development of systemic disease has been 
debated in numerous articles (Forner, 2006). 
 
The National Institute of Dental and Craniofacial Research: National Institutes of Health have 
stated that: “Oral health is not an independent entity which is cut off from the rest of the 
body. Rather it is woven deeply into the fabric of the overall health” (Mani, 2013). 
 
Periodontal pathogens have been implicated in the development of conditions such as 
cardiovascular disorders, diabetes, infective endocarditis, respiratory diseases and a low birth 
weight (Barnett, 2009. Mani, 2013). 
 
Periodontal pathogens are proposed to modify the host’s susceptibility to systemic disease via 
three mechanisms (Li, 2000): 
 
 Shared risk factors 
 
 
There are shared risk factors (such as smoking, stress, aging, race, male gender) between 
periodontitis and systemic diseases (especially cardiovascular disease). 
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 Subgingival biofilms 
 
 
The subgingival biofilms constitute renewing stores of lipopolysaccharides (LPS) and gram- 
negative bacteria. These substances are known to induce major vascular responses (such as 
inflammatory cell infiltrate in vessel walls, vascular smooth muscle proliferation, vascular 
fatty degeneration, intra-vascular coagulation). LPS are also known to up-regulate the 
expression of endothelial cell adhesion molecules (e-CAM), secretion of interleukin-1 (IL-
1), tumour necrosis factor alpha (TNF-α) and thromboxane. These substances result in 
platelet aggregation, formation of lipid-laden foam cells and deposition of cholesterol in the 
tissues – thus creating an environment for the formation of atherosclerotic plaques (Li, 
2000. Barnett, 2009). 
 
 Periodontium as a cytokine reservoir 
 
 
The pro-inflammatory cytokines TNF-α, IL-1β, gamma interferon (γ-IFN) and prostaglandin 
E2 (PGE2) reach very high tissue concentrations in periodontal infections (Li, 2000). Thus a 
diseased periodontium can serve as a reservoir of inflammatory mediators, which re-enter the 
circulation and produce systemic effects. IL-1 and TNF-α are known to cause platelet 
aggregation and adhesion, formation of lipid-laden foam cells and deposition of cholesterol in 
the tissues (Li, 2000). 
 
Numerous periodontal pathogens have been implicated in the pathways which trigger the 
development of cardiovascular diseases (Li, 2000). Antibodies to periodontal organisms have 
also been identified to localize in the heart and trigger complement activation, sensitization 
of T- cells and subsequent heart diseases such as infective endocarditis (Li, 2000. Barnett, 
2009). 
 
The role of periodontal disease in the development of diabetes has also been widely debated. 
A possible mechanism which could increase insulin resistance and potentially contribute to 
the development of diabetes, is the production of oxidative stress-enhancing reactive oxygen 
species (ROS) by the affected periodontal tissues. TNF-α (which reaches high tissue 
concentrations in periodontal diseases) has been identified as an inflammatory mediator 
involved in the pathogenesis of insulin resistance (Bullon, 2009). 
 
The role of periodontal pathogens in the development of respiratory diseases may be related 
to the following mechanisms (Mani, 2013): 
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 Aspiration of oral pathogens (P.g. or A.a.). 
 
 Alteration of the mucosal surfaces by salivary enzymes in periodontal disease 
leading to an increase in the adhesion and colonization of respiratory pathogens. 
 
 The periodontal disease-associated enzymes may destroy the salivary pellicles on the 
pathogenic bacteria. 
 
 Alteration of the respiratory epithelium by cytokines of periodontal disease, which 
facilitate the infection of the epithelium with respiratory pathogens. 
 
It has become increasingly evident that the oral cavity can potentially act as a point of origin 
for the spread of pathogenic organisms to distant sites in the body (Li, 2000). 
 
Transient bacteraemias and dissemination of oral micro-organisms into the bloodstream (with 
spread to the heart, lungs and peripheral blood capillaries) are reported to occur as rapidly as 
1 minute after an oral procedure (Li, 2000. Forner, 2006). 
 
A study by Forner (2006) investigated the development of bacteraemias after procedures such 
as scaling, chewing and tooth brushing in healthy patients with gingivitis or 
periodontitis. Blood was drawn at 5, 10 and 30 minute intervals to assess the presence of a 
bacteraemia. Results of the study showed that a bacteraemia peaked at 5 minutes and tapered 
after 30 minutes. No statistically significant difference between the healthy and gingivitis 
groups were seen when comparing tooth brushing, chewing and scaling, at all three time 
intervals. The incidence and magnitude of the bacteraemia after scaling was greater in the 
periodontitis group. This study suggested that every day events such as mastication and 
tooth brushing, may contribute more significantly than dental procedures, to the cumulative 
exposure of the vascular system to bacteraemias from residing oral micro-organisms 
(Forner, 2006). These bacteraemias have been implicated in the development of distant 
site infections, especially in the cardiovascular system (Forner, 2006). 
 
A systematic review by Horliana (2014) conducted a systematic review to assess the 
magnitude, duration, prevalence and nature of the bacteraemias caused by periodontal 
pathogens, found the available literature too heterogenous to conduct a meta-analysis. The 
review confirmed that more than half of patients will present with a positive bacteraemia after 
periodontal procedures. No definitive data could be determined regarding the magnitude, 
duration and nature of these bacteraemias (Horliana, 2014). 
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Thus the effective treatment of active periodontal diseases and elimination of periodontal 
pathogens can reduce additional burdening of the body with inflammatory mediators and 
pathogens. This will minimise periodontal disease as a risk factor for in the development of 
numerous systemic diseases (Mani, 2013). This illustrates the need for identification of 
adjunctive measures, such as diode lasers, to successfully manage periodontal disease and 
the associated pathogens. 
 
Studies have demonstrated that the diode laser can also be used to “seal” the periodontal 
pockets prior to conventional periodontal treatment in order to reduce the risk of a transient 
bacteraemia (Convissar, 2011:31). This was achieved by application of a 0,4W continuous 
wave for 7-8 seconds on both the buccal and lingual/palatal aspects of the teeth (Convissar, 
2011: 31). 
 
 
 
 
 
1.3. Genetic susceptibility to periodontal disease 
 
 
Bacterial plaque does play an integral role in the initiation of periodontal disease however in 
certain patients the amount of plaque present does not correlate with the severity of 
periodontal destruction seen (Kornman, 1994. Yoshie, 2007). It was thought that 
periodontitis would always develop in those individuals with a history of poor oral 
hygiene and long- standing gingivitis (Laine, 2012). 
 
However, numerous authors have alluded to the fact that certain individuals exposed to 
certain environmental factors, were at a greater risk of developing periodontitis than 
others. Each patient appears to present with an individual “dose-response curve” that 
determines the host’s susceptibility to periodontitis. Thus host response, rather than the 
presence of bacteria is required as the principle determinant of disease expression and 
progression (Yoshie, 2007). 
 
There is a genetic basis to many aspects of the periodontal host response. Data from human 
and animal studies indicate that genetic variance can influence the innate, inflammatory and 
host response to microbial infections (Laine, 2012). It must be emphasized that the 
number and types of disease modifying genes may differ for different types of periodontitis, 
as well as for different population groups (Laine, 2012). 
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IL-1 is a potent pro-inflammatory mediator that is released by macrophages, platelets and 
endothelial cells (Laine, 2012). IL-1 plays an important role in the pathogenesis of 
periodontitis, through its involvement in the regulation of the hosts inflammatory response 
and bone resorption (Kornman, 1997). The IL-1 genotype has been extensively studied as a 
risk factor for susceptibility to periodontal disease (Kornman, 1997). 
 
Kornman (1997) reported that the IL-1 genotype results in an increased secretion of 
interleukin-1, which could serve as a predisposing factor in periodontal disease development 
and progression. Kornman (1997) also found an association between polymorphisms in the 
genes encoding for IL-1α and IL-1β and an association with an increased severity of 
periodontitis. Studies have confirmed that IL-1β levels in both the gingival crevicular fluid 
(GCF) and periodontal tissue biopsies are increased in patients with periodontitis, compared 
to healthy patients or those presenting with gingivitis (Kornman, 1997). 
 
A study by Socransky (2000) compared the microbiological parameters in the IL-1 
genotype negative and positive adults in a convenient sample of subjects with periodontal 
disease. The results from this study revealed that the IL-1 genotype positive patients (with 
pockets greater than 6mm had significantly higher levels of “red” and “orange” complex 
bacteria), compared to shallow (<4mm) and intermediate pockets (4-6mm) (Socransky, 
2000). 
 
A currently available genetic susceptibility test for periodontitis is the Genotype Interleukin- 
1® (Hain Lifescience GmbH, Nehren, Germany). This particular test is based on the patients 
IL-1 genotype (Grigoriadou, 2010). This clinically available test for IL-1 has been 
proposed as a component of the risk assessment profile for periodontitis of a patient. A 
positive test result (identifying the patient as high risk) could reveal the need for more 
effective periodontal therapy, intensive oral hygiene interventions and more frequent recalls 
(Grigoriadou, 2010). 
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1.4. Periodontitis management 
 
 
Numerous studies assessing the management of periodontitis have correlated successful 
periodontal management with elimination or suppression of virulent red complex bacteria 
(Lindhe, 2015:412). However, accomplishing a reduction in the numbers of these 
destructive red complex bacteria, often remains a stumbling block in the management of 
periodontal disease. The red complex bacteria have been demonstrated to infiltrate along 
the tissue capillaries and penetrate the periodontal pocket connective tissue to a depth of 
500 microns, making their elimination with conventional management potentially difficult 
(Convissar, 2011:27). 
 
 
 
The goal of periodontal management is the disruption of the complex biofilm by debridement 
of the contaminated root surface, thereby achieving a reduction in the total bacterial load and 
suppression of target micro-organisms in subgingival areas (Van Winkelhoff, 2005, 
Cheng, 2016). Successful periodontal management is measured both clinically and 
microbiologically and is dependent on the effective removal and elimination of supra- 
gingival and subgingival bacterial biofilms. Eliminating these biofilms enhances biological 
compatibility between the periodontal root surface and the new connective tissue attachment 
(Cobb, 1996a. Greenstein, 2000. Dukic, 2013). 
 
 
 
 
Several management modalities are routinely used for the removal of calcified deposits and 
bacterial biofilms. These include air abrasives, scaling and root planing (using hand 
instruments, ultrasonic and sonic devices) (Scharwz, 2003). These modalities in conjunction 
with patient home care plaque control regimens, are necessary in periodontal disease 
management (Alves, 2012). Conventional management however (i.e. scaling, root planing, 
polishing) has its limitations and is prone to both clinical and microbiological relapse 
(Cheng, 2016). These limitations may be attributed to several factors - such as complex 
tooth anatomy, presence of intrabony defects, limited access associated with size of 
instrumentation and invasion of periodontal pathogens into the surrounding soft tissues 
(Sculen, 2015. Cheng, 2016). Thus identifying treatment modalities that could address these 
limitations, would significantly improve the management of periodontal diseases (Qadri, 
2015). 
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An armamentarium of adjunctive interventions is available, dependent upon the diagnosis 
and management needs of the patient. These adjunctive procedures include antibiotic 
prescriptions and surgical flap procedures. Lasers have recently been proposed as an 
adjunctive intervention (Cobb, 1996a. Socransky, 2002). 
 
 
 
 
 
1.5. Lasers in Periodontitis 
 
 
There are various commercially available lasers, each with a unique range of wavelengths 
and frequencies that can be adjusted according to the procedure requirements (Schwarz, 
2003). Wavelengths differ dependent on the type of laser (such as the gallium–aluminium–
arsenium (GaAlAs) diode laser, Nd:YAG diode laser, Er:YAG laser and CO₂ laser) and these 
wavelengths range from 635-10600nm (Schwartz, 2003). 
 
Diode lasers have been introduced in both general and specialist practices (Convissar, 
2011:7) and are successfully utilized for various intra-oral soft tissues procedures - such as 
frenectomy, gingivectomy, crown lengthening, gingivoplasty, de-epithelization of reflected 
periodontal flaps and tissue biopsies (Cobb, 2010). 
 
Numerous studies investigating the application of diode lasers in the management of chronic 
periodontitis have been published, however these studies have yielded controversial results. It 
was also difficult to compare the findings of these studies, due to variation in the laser wave 
lengths utilized and clinical parameters assessed (Cobb, 2006). The majority of studies 
focused mainly on clinical outcomes, with no evaluation of changes in bacterial load within 
the periodontal pockets following laser application. Thus the true effect of the diode laser on 
the pocket biofilm has not been established (Convissar, 2011:27). 
 
 
 
 
The aim of this thesis was to compare the diode laser (with a wave length of 810± 10 nm) as 
an adjunct to conventional periodontal management (i.e. scaling, root planing and polishing) 
alone at the initial phase of therapy, in patients with chronic periodontitis. 
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CHAPTER 2: LITERATURE REVIEW 
 
 
2.1. Diode laser 
 
 
Diode lasers have varying wave lengths ranging from 810 – 1064 nm. A variety of functions 
and effects can be achieved with a diode laser, dependant on the wavelength and energy 
setting on the laser control unit. The laser can produce coagulation, anaesthesia, ablation, 
incision or simple heating of the tissues (Cobb, 2006b). These lasers have also been reported 
to disinfect and de-epithelialize the gingival sulcus (Zingale, 2012). 
 
Diode lasers emit an invisible laser light, with a wavelength of 810 ± 10nm. This wavelength 
falls within that portion of the non-ionizing radiation spectrum called thermal radiation 
(Convissar, 2011:15). 
 
The laser functions on the principle of energy transmission and emission to the area where 
the laser beam is focused. Four tissue interactions can occur during laser application, namely 
reflection, transmission, scattering and absorption. Transmission occurs by virtue of the 
crevicular fluid in the periodontal pocket as it does not absorb the laser light. In biologic 
tissues, scattering of the absorbed laser energy occurs upon deep tissue penetration. This 
absorbed energy is converted to heat and therefore increases the tissue temperature 
(Convissar, 2011:21). 
 
Bacteria (such as the red complex micro-organisms) have been demonstrated to penetrate the 
periodontal pocket connective tissue to a depth of 500 microns (Convissar, 2011:27). 
Diode lasers can penetrate 1-3mm into the tissues (Convissar,  2011:23). This depth of 
penetration is influenced by many factors. These include the presence of chromophores (e.g. 
haemoglobin and pigments like melanin), inflammation and the power/energy settings of the 
laser (Figure 2). 
 
Studies have shown that diode lasers with 980 nm wavelength (Figure 2) are well absorbed 
by water. There are however no studies stating that superior results can be achieved with the 
980nm laser over other wavelengths of diodes (e.g. 810 nm diode laser) (Figure 2) 
(Convissar, 2011:29).
 
 
 
 
11  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          Figure 2: Co-efficient of absorption of laser energy from various lasers (Blaiden, 2013:6) 
 
 
 
The bacteriocidal properties of lasers are well established (Cobb, 2010). The mechanism 
whereby this occurs is hypothesized to be due to the fact that the laser energy is selectively 
absorbed by dark pigments (photodynamic therapy on the dark pigment), such as melanin and 
haemoglobin (Cobb, 2010). In inflamed periodontal pockets, the increased blood supply due 
to erythema and inflammation causes the laser light to be absorbed by the haemoglobin, 
which is elevated in the inflamed pockets (Blaiden, 2013:30-31). Chromophores (associated 
with periodontal inflammation) will result in greater absorption of laser energy in the 
inflamed tissue compared to the healthy tissue (Blaiden, 2013:30-31). Theoretically an 
initiated tip should only affect and eliminate inflamed tissue, with a lesser effect on the 
healthy tissue in the periodontal pocket (Blaiden, 2013:81). 
 
Deep periodontal pockets also present with higher numbers of pigmented bacteria, thus 
allowing greater absorption of the laser energy (Convissar, 2011). It is thus assumed that the 
laser is effective in reducing the colony numbers of the dark pigmented bacteria, such as 
P.spp, P.spp and T.spp. (Cobb, 2010). 
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Laser application has also been shown to also have an impact on non-pigmented bacteria by 
virtue of its thermal properties, resulting in a temperature increase within the periodontal 
pocket. The absorbed laser energy also stimulates the proliferation of endothelial cells, which 
promotes healing and local blood circulation by way of photobiomodulation (Convissar, 
2011:28). 
 
 
2.2. Application of the diode laser in patients with chronic periodontitis 
 
 
 
The lack of long-term successful treatment outcomes of conventional management in some 
chronic periodontitis cases has emphasized the need for identification of adjunctive 
management modalities, such as diode lasers (Qadri, 2015). 
 
Four studies comparing the application of the diode laser (at a wave length of 810 ± 10 nm), 
as an adjunct in the management of chronic periodontitis are tabulated below (Table 1). 
 
 
Table 1: Comparison of studies utilizing a diode laser with a wavelength of 810 ± 10 nm as 
an adjunct in the management of chronic periodontitis. 
 
 
Author 
 
Laser 
 
No of 
Participants 
 
Power 
 
Time 
 
Technique 
 
Improvement in 
clinical 
parameters (test 
vs control) 
 
Improvement 
in bacterial 
load(test vs 
control) 
 
Moritz, 
1998 
 
809 nm 
 
50 
 
2.5 W, 400 
µm 
 
10 seconds 
 
Pocket lased 
 
None assessed 
 
No statistical 
significance 
 
 
 
 
Kreisler, 
(2005) 
 
809 nm 
 
22 
 
1.0 W, 600 
µm 
 
10 seconds, 
interruption 
30 sec. 
 
Fiber parallel to 
pocket.Moved 
along long axis of 
tooth  1 mm 
coronal to 
periodontal 
pocket. 
 
Improvement  - 
Statistically 
significant for 
PPD, CAL. 
 
(Parameters 
assessed:  Clinical 
attachment loss, 
tooth mobility, 
Pocket depth, 
plaque index, 
gingival index, 
sulcus  fluid  flow 
rate) 
 
None assessed 
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Zingale, 
(2012) 
 
810 nm 
 
25 
 
0.9 W, 
?µm 
 
30-45 sec 
(cv) 
 
Removal of 
pocket epithelium 
 
Improvement- No 
statistical 
significance 
 
(Parameters 
assessed: bleeding 
on probing, 
clinical 
attachment loss, 
pocket depth) 
 
None assessed 
 
Alves 
2013 
 
808±5 
nm 
 
36 
 
1.5 W, 400 
µm 
 
20 seconds 
 
Pocket lased 
 
Improvement - No 
statistical 
significance 
 
(Parameters 
assessed: clinical 
attachment loss, 
pocket depth, 
Bleeding on 
probing, 
recession, plaque 
index) 
 
Improvement 
– no statistical 
significance 
 
 
 
 
 
 
Patients with a confirmed diagnosis of chronic periodontitis and probing pocket depth 
(PPD) of >4mm were included in the studies (Table 1) Two studies utilised a split mouth 
technique (Kriesler, 2005. Alves, 2013) and assessed the efficacy of scaling, root planning 
and polishing with laser (test group) compared to scaling, root planning and polishing 
alone (control group). Moritz (1997) performed his study on 49 patients (12 in the 
control group and 37 in test group). The study of Moritz (1997) was included in this review 
as he used a diode laser (809 nm) and it is one of the only two studies that assessed bacterial 
changes. Moritz conducted a similar study in 1998, however the control group rinsed with 
hydrogen peroxide. This study was thus not included for comparison due to the potential 
chemical interactions of the hydrogen peroxide (Moritz, 1998). Zingale (2012) compared 
no treatment (control group) to conventional management, as well as conventional 
management with the laser. Thus the study of Zingale (2012) was included in this review. 
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Most of the studies assessed the same clinical parameters, namely probing pocket depth 
(PPD), recession (REC), clinical attachment loss (CAL), full mouth plaque score and 
bleeding on probing scores (BOP) for the patients participating in the studies. 
 
 
 
 
 
2.3. Bacterial collection and assessment of bacterial parameters 
 
 
 
Bacterial collection is essential to assess the effectiveness of interventions for the 
decontamination of the periodontal pockets. The identification and isolation of periodontal 
pathogens in periodontal diseases can also aid the clinical management of the disease and 
assist in assessment of the tissue response to therapy (Van Winkelhoff, 2005). 
 
The laser energy has the potential to decontaminate and eliminate the bacteria in the 
periodontal pocket. The identification and assessment of the bacterial load is an essential part 
of measuring the reduction of the bacterial colonies in the periodontal pocket. Only two 
studies in Table 1 (Alves, 2013. Moritz, 1997), collected bacteria and counted the colony 
forming units (CFU’s). The total bacterial load and number of black pigmented bacteria were 
also assessed and found to be reduced, however this reduction was not statistically significant 
(Moritz, 1997. Alves, 2013). 
 
The studies of Moritz (1997) and Alves (2013) used bacterial culturing techniques to 
analyse the subgingival micro-organisms. Bacteria were collected with sterile paper points 
and cultured in petri dishes, after which colony forming units (CFU) were counted. Specific 
black pigmented bacterial colonies were identified via gram staining. The drawback with the 
agar plate method for the counting of CFU is that there are bacteria that could be 
incorrectly identified, since they look similar on the growth medium, possibly resulting in a 
higher CFU identification number for that bacteria. An example of such a bacteria is 
Haemophilus aphrophilus ( H . a ) that has been frequently misinterpreted as A.a or P.i. 
Molecular microbial techniques – such as PCR have become available to assess periodontal 
pathogens, which overcomes these drawbacks (Boutaga, 2006). 
 
PCR identifies and quantifies micro-organisms with a higher level of sensitivity and 
specificity. PCR is more sensitive to those bacterial species that are often difficult to culture 
(such as anaerobic organisms (Boutaga , 2006).   A study by Boutaga  (2006) 
 
 
 
 
15  
compared anaerobic bacterial culture and PCR techniques in the identification and 
quantification of periodontal pathogens. Boutaga (2005) demonstrated that the detection 
frequency in percentage of the specified bacteria for PCR was greater than that with CFUs on 
agar plates (Table 2) (Boutaga, 2005). This study concluded that PCR was more sensitive in 
detecting smaller numbers of pathogens compared to the culture techniques. PCR is also a 
rapid diagnostic tool, while the culture techniques requires approximately 14 days to yield the 
bacterial specimen for assessment (Boutaga, 2006). Thus PCR can be utilised as a rapid and 
highly sensitive diagnostic tool in the evaluation of periodontal pathogens in a periodontal 
pockets. 
 
 
 
 
 
Table 2: Detection frequency in % of PCR vs CFU (Boutaga, 2005) 
 
 
 
Bacteria 
 
PCR (%) 
 
CFUs agar plate 
(%) 
 
A.a 
 
27.4 
 
21.6 
 
P.i 
 
83 
 
63.7 
 
T.f 
 
89.2 
 
83 
 
P.m 
 
97.3 
 
91.9 
 
 
 
 
 
 
Only two of the relevant studies (Table 1) identified and assessed the changes in bacterial 
load within the periodontal pockets (Alves, 2012. Moritz, 1997). This omission of bacterial 
load assessment by the majority of studies may identify an additional area of study required 
to validate the efficacy of the diode laser as an adjunct to conventional scaling, root planing 
and polishing. It would be of value to assess the changes in bacterial load in the 
periodontal pockets with a highly sensitive and specific technique such as polymerase chain 
reaction (PCR). 
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A commercially available kit - Micro-IDent
®
-11 (Hain Lifescience GmbH, Nehren, 
Germany) is based on multiplex PCR of 16S rDNA followed by simultaneous reverse 
hybridization. The Micro-IDent
®
-11 has been demonstrated to be accurate for use in 
periodontal pathogen detection to a significant correlation with real time PCR (Haffejee, 
2009. Eick, 2011). 
 
 
 
 
 
2.4. Conclusion 
 
 
Periodontal diseases affect most populations worldwide (Lindhe, 2015:449), thus illustrating 
the importance of developing effective management modalities to manage and prevent 
progression of periodontal disease. 
 
The findings studies assessing the diode laser as an adjunct to conventional periodontal 
management were diverse. The study of Moritz (1997) concluded that the diode laser 
achieved considerable bacterial elimination from periodontal pockets. One study concluded 
that the diode laser improved clinical parameters and was a potential adjunct to conventional 
scaling and root planing (Kriesler, 2005). Two studies concluded that the diode laser was not 
of any additional benefit to conventional management (Zingale,  2012. Alves,  2013). The 
diversity in these results can perhaps be attributed to heterogeneity of the study parameters, 
making direct comparisons or conclusions difficult (Cobb, 2006b. Boutaga, 2006). 
 
The authors concurred on the potential use of diode lasers as an adjunct to conventional 
management in the treatment of periodontitis. Further studies however are required (Moritz, 
1997. Kriesler, 2005). Assessment of changes in the bacterial load, with the diode laser as 
an adjunct, should be performed by a highly sensitive diagnostic tools, such as PCR, to 
determine the effect of the diode laser on the bacterial colonies (Boutaga, 2006). 
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CHAPTER 3: RESEARCH DESIGN AND METHODOLOGY 
 
 
Terms utilized in this chapter 
 
 
 Chronic periodontitis: defined as inflammation of the gingiva extending into the 
adjacent attachment apparatus - characterized by a loss of clinical attachment due to 
the destruction of the periodontal ligament and supporting alveolar bone (Parameters 
of Care – American Academy of Periodontology, 2000).  
 Conventional (periodontal) management: refers to scaling, root planing and polishing 
only. 
 Control quadrants: refers to study quadrants receiving conventional management 
only. 
 Test quadrants: refers to the study quadrants receiving conventional management and 
laser application as an adjunct. 
 Clinical parameters: refers to clinical indices measured - consisting of probing 
pocket depth (PPD), recession (REC), tooth mobility, plaque scores and bleeding on 
probing scores (BOP). 
 Red complex bacteria: refers to the groups of bacterial pathogens as described by 
Socransky (1998). This group includes P.g, T.d and T.f. 
 
 
 
 
3.1. Introduction 
 
 
A literature search revealed no published standardised guidelines on the management of 
periodontal disease with an 810 ± 10nm laser. In addition, the available studies demonstrated 
no consistency in study methodologies nor laser parameters utilized. 
 
Boutaga (2006) established polymerase chain reaction (PCR) to be more effective than 
counting of CFU’s for the assessment of bacterial parameters. Thus a PCR technique was 
utilised in this study to assess the bacterial load changes of eleven pathogens (with 
emphasis on the destructive red complex bacteria). This was performed using a 
commercially available kit – the Micro-IDent®-11 (Hain Lifescience GmbH, Nehren, 
Germany). 
 
The changes in clinical parameters were also assessed based on standard measurements 
currently utilised in periodontal assessment. Standard clinical goals / parameters utilised 
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during periodontal assessment of patients include tooth mobility, CAL, REC, PPD, plaque 
scores and BOP (Lindhe, 2008:573). 
 
 
AIM 
 
 
To assess the efficacy of a diode laser in improving clinical parameters and bacterial load 
reduction of red complex organisms, as an adjunct to initial phase therapy in patients with 
chronic periodontitis. 
 
OBJECTIVES 
 
 
 To compare the quantitative changes in the bacterial load of pathogens in the 
periodontal pocket after conventional management versus conventional management 
plus the diode laser. 
 To compare the difference in the periodontal clinical parameters after conventional 
management versus conventional management plus the diode laser. 
 
 
 
 
MATERIALS AND METHODS 
 
 
3.2. MATERIALS 
 
 
The following materials were utilized in this study: 
 
 
Laser (Figure 3): 
 
 
Protective  eye  wear for  810nm, Diode laser: Picasso  GaAlAs diode laser  (AMD Laser, 
Indiana, USA), Diode hand piece, Fiber stripper, Fiber cutter 
 
Hand instrumentation: 
 
 
Gracey  curettes  (Maillefer, Sirona Dentsply),  Mini   fives  (Hu-Friedy  Co,  Chicago,  
Illinois), 
 
Periodontal probe (Maillefer, Sirona Dentsply), Ultradent 
capillary tips known as “canula”. 
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Bacterial and Genotype collection PCR kits (Figure 6, 7): 
 
 
Bacterial collection: Micro-IDent
®
-11 (Hain Lifescience GmbH, Nehren, Germany). 
Periodontal risk assessment: Genotype Interleukin- 1
®
 (Hain Lifescience GmbH, Nehren, 
Germany) (Chondros, 2009). 
 
Prophylaxis: 
 
 
Medium abrasion polishing paste (Nu-Pro polishing paste, Sirona Dentsply), Rapid Care 
Sensodyne tooth paste (GSK), ART-PB3 Piezo-electric scaler (BonART®,  New Taipei City, 
Taiwan). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Picasso laser and essential accessories 
 
 
Each time the laser tip was cleaved it was viewed under a magnifying class at 2X 
magnification. The fiber was cleaved in accordance to the manufacturer instructions. This is 
essential since a properly cleaved fiber to ensure a uniform beam profile (Figure 4). 
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Figure 4: Illustration of the beam profile depending on cleaving status (Blaiden, 2013:23). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Correctly cleaved fiber assessed under 2X magnification. 
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3.3. METHODS 
 
 
3.3.1. Study design 
 
 
A split mouth randomized control trial was employed, in which every subject is treated with 
at least two treatments, each being applied to a different area of the mouth (Antczak- 
Bouckoms, 1990). This technique allows the patient to be the test subject and control. 
(Lesaffre, 2009). 
 
The subjects selected in this study were diagnosed with chronic periodontitis (based on the 
inclusion criteria according to the American Academy of Periodontology Classification, 
1999 ). Two quadrants (one maxillary and one mandibular) were utilised as the test quadrants 
and the contra-lateral quadrants served as the control quadrants. 
 
 
 
 
 
3.3.2. Sampling 
 
 
The study population comprised of twenty five patients diagnosed with active chronic 
periodontitis, who presented at the Oral Medicine and Periodontology Department of the 
University of the Western Cape. These patients provided informed consent and recruitment 
procedures were in accordance with good clinical practice. 
 
3.3.3. Inclusion criteria: 
 
 
The participants had to be adult patients ( over the age of 18 years). For the purpose 
of this study the participants were diagnosed with chronic periodontitis and had to present 
with a minimum of four teeth present per quadrant. At least three teeth per quadrant had to 
present with periodontal probing pocket depths of 5mm or more in any of the six point 
probing areas namely mesio-buccal (MB), buccal (B), disto-buccal (DB), mesio-palatal (MP), 
palatal (P), disto-palatal (DP) per tooth were assessed. 
 
Clinical features defining a diagnosis of chronic periodontitis: 
 
 
 Oedema and tissue erythema 
 
 Moderate accumulations of plaque and calculus 
 
 Bleeding on probing (BOP) 
 
 Increased pocket depths (minimum probing pocket depth of 4mm) 
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 Radiographic evidence of bone loss (angular or horizontal) 
 
 Tooth mobility 
 Varying degrees of clinical attachment loss 
 
 Slow to moderate rate of progression 
 
 Amount of destruction consistent with the presence of local factors – such as plaque 
and calculus. 
The chronic periodontitis could have presented as localised (<30% of sites affected) or 
generalized (>30% of sites affected). The severity of the chronic periodontitis could have 
presented as mild (CAL= 1-2mm), moderate (CAL=3-4mm) or severe (CAL > 5mm) 
(Lindhe, 2015:129). All the above mentioned variants of chronic periodontitis were 
included in this study. 
 
 
 
 
 
3.3.4. Exclusion criteria 
 
 
The only underlying medical conditions that were excluded were patients that were pregnant 
(or lactating) and patients undergoing radiation or chemotherapy (Kreisler, 2005). 
 
Patients with oral pigmentation of the attached gingiva in the study area of interest were also 
excluded from the study, as pigments (such as melanin) absorb laser energy at varying 
amounts which could potentially have an effect on the results (Convissar, 2011:150). 
 
Patients who smoked more than 10 cigarettes per day were excluded (Kreisler, 2005). 
Patients that had taken antibiotics in the previous 6 months were excluded (Alves, 2012). 
Patients who had periodontal treatment in the previous 6 months were also excluded (Alves, 
2012). 
 
 
 
3.3.5. Selection of test and control quadrants 
 
 
Quadrants 1 & 4 (Q1 & Q4) were assessed together and Q2 & Q3 were assessed together. 
This selection procedure for which quadrants received the adjunctive laser therapy could 
potentially introduce bias (Hujoel, 1998). In order to eliminate bias of quadrants 
selection, subjects selected one of two coloured balls from a closed, non-transparent bag – for 
example a blue (representing conventional management alone) and a red ball (representing 
the diode laser as an adjunct to conventional management). The first ball selected determined 
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which treatment is performed on Q1 & Q4. The remaining treatment option was then applied 
to Q2 & Q3. The clinician was blinded to which quadrants were test quadrants, as the 
selection of the coloured balls designating the test and control quadrants was only 
performed after the conventional management (i.e. scaling, root planing and polishing) 
was completed. The treatment was performed by one clinician after calibration of the 
prescribed conventional management technique by a Specialist Periodontist in the 
Department. 
 
 
 
 
 
3.3.6. ASSESSMENT OF CLINICAL PARAMETERS 
 
 
3.3.6.1. Probing pocket depth (PPD) 
 
 
PDD was measured to the nearest millimetre (with a graduated periodontal probe 
(Maillefer, Sirona Dentsply)) from the gingival margin to the base of the clinical pocket 
(Lindhe, 2015:564). Six sites (MB, B, DB, MP, P, DP) per tooth were assessed. 
 
3.3.6.2 Recession (REC) 
 
 
The Millers classification (1985) for recession was used to determine the recession. REC was 
measured (with a periodontal probe) to the nearest millimetre from the cemento-enamel 
junction to the gingival margin. 
 
3.3.6.3 Clinical attachment level (CAL) 
 
 
CAL was measured (with a periodontal probe) as the distance in millimetres from the 
cemento-enamel junction (or the border of a restoration) to the base of the probable pocket 
(Lindhe, 2015:126). 
 
3.3.6.4 Full mouth plaque score: 
 
 
A full mouth plaque score was calculated by adapting the Plaque Index by Silness & Löe 
(1964) and applying this index to every tooth. 
 
 Index values : 
 
 
0: No visible plaque 
 
 
1: Plaque disclosed on probing 
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2: Visible plaque 
 
 
3: Abundant plaque (Lindhe, 2015:126). 
  
 
 
3.3.6.5. Full mouth bleeding on probing (BOP): 
 
 
BOP for all teeth was calculated as a percentage of the total number of pockets presenting 
with bleeding on probing, for quadrants Q 1 & Q4 as a set and Q2 & Q3 as a set. 
 
3.3.6.6. Tooth mobility 
The Millers criteria (1950) was used to assess tooth mobility. 
Tooth mobility index: 
 Degree  0:  Normal  physiological  tooth  movement  of  between  0,1-0,2  mm  in  a 
horizontal direction. 
 Degree 1: Increased mobility of the tooth to at most 1mm in a horizontal direction. 
 
 Degree 2: Visually increased mobility of the tooth exceeding 1mm in a horizontal 
direction. 
 Degree 3:   Severe mobility of the tooth both in a horizontal and vertical direction 
(Lindhe, 2015:126). 
 
 
 
 
These clinical parameters were recorded at the initial visit and repeated after 6 weeks (Alvez, 
2013). 
 
A study conducted Morrison (1980) demonstrated that the clinical severity of periodontitis 
is reduced significantly 1 month following the initial phase therapy (i.e. conventional 
management). Thus the assessment of clinical and microbiological parameters cannot be 
assessed before 1 month of healing has occurred (Morrison, 1980). 
 
At the initial and subsequent visits oral hygiene instructions and education regarding the 
importance of adequate plaque removal was provided. Patients were shown how to brush all 
the teeth twice a day for two minutes with the modified Bass technique after evening flossing 
(Löe, 2000). A soft bristled brush with a pea sized amount of the provided Rapid Care 
Sensodyne toothpaste was used. The patients were instructed not to use any form of mouth 
rinse during the duration of the study, since it could influence the outcome of treatment. 
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3.3.6.7. Collection of bacteria and assessment of bacterial load 
 
The analysis of the collected bacteria includes the following micro-organisms: 
 
 
 Actinobacillus actinomycetemcomitans (A.a.) 
 
 Porphyromonas gingivalis (P.g.) 
 
 Prevotella intermedia (P.i.) 
 
 Tannerella forsythia (T.f.) 
 
 Treponema denticola (T.d.) 
 
 Peptostreptococcus micros (P.m.) 
 
 Fusobacterium nucleatum (F.n.) 
 
 Campylobacter rectus (C.r.) 
 
 Eubacterium nodatum (E.n.) 
 
 Eikenella corrodens (E.c.) 
 
 Capnocytophaga species (C.s.). 
 
 
 
The first collection of bacteria was performed during the initial assessment appointment prior 
to any treatment being performed. 
 
Bacteria was collected from the sub-gingival aspect of periodontal pockets with a 
commercially available kit, namely Micro-IDent
®
-11(Hain Lifescience GmbH, Nehren, 
Germany) (Figure 6) (Chondros, 2009). The manufacturer stated that as the analysis is DNA- 
based, no special terms of transport need to be observed. Samples may be stored in the 
refrigerator. In this study the collected samples were refrigerated immediately after collection 
and couriered in a refrigerated cooler within 24 hours of collection. 
 
The bacteria samples were collected according to the manufacturers’ instructions from the 
periodontal pockets on the buccal and lingual/palatal aspects of teeth. One sterile paper point 
(per tooth) was inserted on the buccal and lingual/palatal aspects. All the paper points of 
quadrant Q1 & Q4 were grouped together to make an extract for one PCR-test and Q2 & Q3 
was grouped together for one PCR-test. 
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Six weeks after the first visit (conventional management alone (Control side) / conventional 
management plus laser application (Test side) another set of paper points was collected for 
the grouped quadrants (Q1 & Q4, Q2 & Q3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Micro-IDent
®
-11 (Hain Lifescience GmbH, Nehren, Germany). 
 
 
The periodontal risk status was also assessed at this stage with the Genotype Interleukin- 1
® 
(Hain Lifescience GmbH, Nehren, Germany) (Figure 7) (Chondros, 2009). No other laser 
study has taken the patients’ genetic predisposition to periodontal disease into account. It this 
study the Genotype IL-1 was determined, but it did not serve as an inclusion or exclusion 
criteria for patient participation in the study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Genotype Interleukin- 1
®
 (Hain Lifescience GmbH, Nehren, Germany).
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3.3.6.8. Description of procedure for microbial PCR analysis (performed by Hain 
Lifesciences) 
 
DNA isolation 
 
 
DNA isolation from the paper points: 400 μl 5% Chelex 100 in 10 mM Tris pH 8.5 were 
added to every sample. After centrifugation of the paper points, the samples were placed in 
an ultrasonic bath (Branson 5510) at 60°C for 15 min. Finally, the samples were incubated 
for 15 min in a 105°C thermo-block. Following centrifugation, 5 μl was used for the 
polymerase chain reaction (PCR). 
 
 
 
 
 
PCR amplification: 
 
 
PCR amplification was carried out in a reaction volume of 50 µl, consisting of 5 μl of 
template DNA and 45 µl reaction mixture containing 35 μl primer nucleotide mix (multiplex 
Micro-IDent
®
 kit) , 5µl of 10X PCR buffer (Qiagen), 5µl of 25 mM MgCl2 and 1U Taq 
polymerase (Qiagen). The amplification profile was one cycle at 95°C/5 min, ten cycles at 
95°C/30 s and 58°C/2 min, 20 cycles at 95°C/25 s, 53°C/40 s and 70°C/40 s and one final 
cycle at 70°C/8 min. For the species Peptostreptococcus until Capnocytophaga, a second 
primer nucleotide mix was used (multiplex Micro-IDent
®
 -11 Plus kit). 
 
 
 
 
 
Reverse hybridization: 
 
 
For the automatic executed hybridization, an Apollo blot automat (Matec) was used; 20 μl of 
the amplified sample is mixed with 20 μl of the denaturizing solution, for 5 min at room 
temperature. One milliliter of pre-warmed hybridization buffer was added. The specific DNA 
probes for the reverse hybridization are fixed on a membrane strip. Under gentle shaking, the 
strip was incubated for 30 min at 45°C. After aspiration of the hybridization buffer, 1 ml of 
stringent wash buffer was added and the strip was incubated for 15 min at 45°C. The strip 
was washed for 1 min with the rinse solution at room temperature. The conjugate 
(streptavidin-conjugated alkaline phosphatase) was added, and the strip was incubated for 30 
min at room temperature. After being washed twice for 1 min with water, the strip was dried 
between absorbing papers, and the results are evaluated, quantified and interpreted. Validated 
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quantitative and qualitative test samples are used as control samples. Bacterial levels were 
expressed as genome equivalents (< 10
3
=0, 10
3
 to 10
4
=1, 10
4
 to 10
5
=2and 10
5 
to 10
6
=3). 
The test has a detection limit of 10
3
 genome equivalents. 
 
 
 
 
3.4. Conventional management that was performed 
 
The clinical parameters, bacterial sampling and assessment of periodontal status was 
performed prior to the application of conventional management. All the quadrants (1, 2, 3, 
4) were treated in the same visit. Ultrasonic debridement of plaque and calculus deposits 
were completed with an ART-PB3 Piezo-electric scaler (BonART
®
, New Taipei City, 
Taiwan) at a frequency range of 27-32 kHz. Mechanical sub-gingival debridement was 
performed with Gracey hand curettes and mini fives (Hu- Friedy Co., Chicago, Illinois). 
The supra-gingival tooth structure and root surfaces were completely debrided for all the 
teeth present in the patient’s oral cavity. Supra -gingival tooth structure was polished with 
medium abrasion polishing paste (Nu-Pro polishing paste, Sirona Dentsply) and a polishing 
cup fitted on a slow hand piece. 
 
 
 
 
 
3.5. Laser decontamination of test quadrants 
 
 
3.5.1. Laser decontamination settings 
 
 
The Picasso GaAlAs laser (AMD Lasers
®
, Indianapolis, Indiana, USA) with a wavelength 
of 810 ± 10 nm was used. The laser was used with a 400µm (0.4mm) optical fibre 
(Figure 3). The tip was cleaved and assessed under magnifying glass at 2X 
magnification to ensure a square cleavage of the tip (Figure 5). Incorrect cleavage will 
result in irregular laser light distribution (Blaiden, 2013:23) (Figure 4). For periodontal 
pocket decontamination it is recommended that the laser tip must be initiated. This is 
achieved by placing the tip on cork or articulating paper. Initiated tips require less 
energy to achieve the same amount of energy delivery to the tissues than a non- initiated 
tip. This has the advantage of decreasing the temperature and the lasing time required, thus 
reducing the risk for thermal damage to the periodontal structures (Convissar, 2011:31). 
 
Studies have demonstrated “sealing” of the periodontal pockets prior with the diode laser 
prior  to  conventional  management  in  order  to  reduce  the  risk  of  creating  a  transient 
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bacteraemia (Convissar, 2011:31-32). In order for this study to be a randomized control trial 
this technique was not utilised. This would result in identification of the test quadrants 
prior to the conventional management – introducing the risk of bias. 
 
The laser application in the test quadrant pockets occurred after the tip was initiated on 
articulation paper. The power setting of 1W continuous wave was selected. The Picasso 
GaAlAs laser (AMD Lasers
®
, Indianapolis, Indiana, USA)  was set at continuous wave for 
the “decontamination” on 1W (Kreisler, 2002) at a frequency of 50Hz (Moritz, 1997). 
 
 
 
 
 
3.5.2. Application of the laser in the quadrants receiving laser treatment and 
conventional management (Test quadrants) 
 
The laser tip was applied in the pocket for the extent of time that was needed to sweep the tip 
through the pocket. This time was maintained at 8 ± 2 seconds per buccal aspect of the tooth 
and about 8 ± 2 seconds per lingual/palatal aspect of the tooth. The tip was held parallel to 
the long axis of the tooth and 1mm coronally of the periodontal base of the pocket. In order to 
ensure that the laser tip is placed at the correct pocket depth, a plastic canula was calibrated in 
millimetre segments (as found on a periodontal probe) and placed over the laser fibre and 
hand piece before laser decontamination commenced (Figure 8). The periodontal pocket 
depths from the clinical parameters served as a reference guide. If a deeper pocket required a 
longer fiber, the fiber could simply be fed through the hand piece. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Illustration of how canula was calibrated for the laser fiber 
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All the laser treatment commenced from the most distal tooth of the test quadrants towards 
the most mesial. Decontamination started on the buccal aspect of the tooth, from the distal 
aspect of the periodontal pocket to the mesial aspect of the periodontal pocket and then 
repeated on the lingual/palatal aspects of the teeth. The periodontal pockets of all the teeth of 
the test quadrants were rinsed with saline and a calibrated irrigation tip to allow appropriate 
depth in the pockets, based on the periodontal charting (Figure 9). Following the lasing and 
saline rinse the laser decontamination was repeated for a second time for an additional 8 
seconds at the buccal and palatal/lingual aspects of the teeth. This timeframe was chosen 
based on the research conducted by Kreisler (2005), whom suggested 10 seconds will cause 
thermal damage and bacterial decontamination of more than 99% simply cannot be achieved. 
Damage to the root surface also occurred at settings of 1.5W and higher (Kreisler, 2005). In 
order to avoid any patient discomfort treatment was completed under local anaesthetic. 
Xylotox Plain
® 
was used in order to ensure that the presence of adrenalin could potentially 
not have an impact on the level of chromophores in the periodontal pocket. The necessary 
personal protective equipment to operate the laser was worn by the operator and the patient. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Calibrated Ultradent Navi 29G, 17mm tip for saline rinse. 
 
 
 
 
31  
3.6. STATISTICAL ANALYSIS 
 
 
3.6.1. Reporting of the data 
 
 
The bacterial report from the Micro-IDent
®
-11 is demonstrated in Figure 11. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Bacterial report from the Micro-IDent
®
-11 kit. 
 
 
 
 
 
The Micro-IDent
®
-11 report provides the bacterial pathogen load as crude “ < and >” 
ranges. To facilitate statistical analysis these crude ranges were converted to pathogen 
concentration ranges and captured as decimal values (as established with the manufacturer) 
(Table 3). 
 
 
Table  3:  Interpretation  of  Micro-IDent
®
-11  pathogen  concentration  for  data  capturing 
purposes for all the pathogens (excluding A.a.). 
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KEY 
 
Pathogen 
concentration 
 
Exact pathogen 
concentration range 
(As established with 
the manufacturer). 
 
Captured in data sheet 
to facilitate statistics 
 
(As established with the 
manufacturer). 
 
- 
 
<104 
 
100-103.99 
 
0.35 
 
(+) 
 
104 
 
104 
 
0.4 
 
+ 
 
<105 
 
104.01-104.99 
 
0.45 
 
++ 
 
<106 
 
105-105.99 
 
0.55 
 
+++ 
 
≥106 
 
106-10∞ 
 
0.6 
 
 
 
 
 
Table 4 illustrates the pathogen concentration as per the Micro-IDent
®
-11 and the results 
captured to facilitate statistical analysis for A.a. 
 
Upon analysis the values are converted back to the range for accuracy and interpretation 
purposes. 
 
Table  4:  Interpretation  of  Micro-IDent
®
-11  pathogen  concentration  for  data  capturing 
purposes 
 
 
 
KEY 
 
Pathogen 
concentration 
A.a 
 
Pathogen 
concentration range 
(As established with 
the manufacturer). 
 
Captured in data sheet 
to facilitate statistics 
 
(As established with the 
manufacturer). 
 
- 
 
<103 
 
100-102.99 
 
0.25 
 
(+) 
 
103 
 
103 
 
0.3 
 
+ 
 
<104 
 
103.01-103.99 
 
0.35 
 
++ 
 
<105 
 
104-104.99 
 
0.45 
 
+++ 
 
≥105 
 
105-10∞ 
 
0.5 
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The data capturing from the bacterial report (Figure 10) was efficient since a clear parameter 
was established with the manufacturer (Table 3; Table 4). This facilitated the statistical 
analysis for the 25 patients taking the decimal values into consideration to achieve a greater 
level of accuracy. The Micro-IDent
®
-11 report visually illustrates the bacterial parameter 
sensitivity range (Figure 10). 
 
Table 5 was constructed to demonstrate the discrepancy between evaluating the bacterial 
parameters as a crude “ < ” and “ > ” values, compared to assigning decimal values. 
 
Based on Table 5 using T.d as example the control side had statistical significant bacterial 
load decreases based on the decimal values. The conclusion for control side for T.d was that 
the bacterial load changed from 0.47 to 0.41 based on decimal values, however the crude 
representation (<105) indicated no change. But for the 25 patients the bacterial change was 
significantly decreased in the control group. This illustrates the need for decimal values for 
statistical analysis of bacterial parameters when PCR analysis is performed. 
 
 
Table 5: Micro- IDent bacterial range applied to the test and control sides to illustrate the 
precise bacterial parameter range after 6 weeks. 
 
 
Differences for the bacterial parameters of the Micro-IDent
®
-11 
 
 
 
 
 
 
 
Bacteria: 
A.a 
 
 
 
 
 
 
 
 
n 
 
 
 
 
 
 
 
Before 
treatment 
 
 
 
 
 
 
 
After 
treatment 
 
 
 
 
 
Micro-
IDent 11 
parameter 
difference 
 
Statistical 
difference 
found with 
the actual 
captured 
decimal value 
 
Control 
side 
 
 
 
25 
 
 
0.28 (<103) 
 
 
0.294 (<103) 
 
 
 
none 
 
none 
 
Test side 
 
25 
 
0.29 (<103) 
 
0.298 (<103) 
 
none 
 
none 
 
Bacteria: 
P.g 
 
 
Control 
side 
 
 
 
25 
 
0.468 
(<105) 
 
 
0.448 (<105) 
 
 
 
none 
 
none 
 
 
 
Test side 
 
 
 
25 
 
0.468 
(<105) 
 
 
0.44 (<105) 
 
 
 
none 
 
none 
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Bacteria: 
T.f 
 
 
Control 
side 
 
 
 
25 
 
 
0.49 (<105) 
 
 
0.474 (<105) 
 
 
 
none 
 
none 
 
 
 
Test side 
 
 
 
25 
 
0.482 
(<105) 
 
 
0.47 (<105) 
 
 
 
none 
 
none 
 
Bacteria: 
T.d 
 
 
Control 
side 
 
 
 
25 
 
 
0.47 (<105) 
 
 
0.41 (<105) 
 
 
 
none 
 
Yes 
 
 
 
Test side 
 
 
 
25 
 
 
0.4 (104) 
 
 
0.424 (<105) 
 
bacterial increase 
(104 to 105) 
 
none 
 
Bacteria: 
P.i 
 
 
Control 
side 
 
 
 
25 
 
0.424 
(<105) 
 
 
0.392 (<104) 
 
bacterial decrease 
(105 to 104) 
 
none 
 
 
 
Test side 
 
 
 
25 
 
0.388 
(<104) 
 
 
0.394 (<104) 
 
 
 
none 
 
none 
 
Bacteria: 
P.m 
 
 
Control 
side 
 
 
 
25 
 
0.394 
(<104) 
 
 
0.366 (<104) 
 
 
 
none 
 
none 
 
 
 
Test side 
 
 
 
25 
 
0.374 
(<104) 
 
 
0.382 (<104) 
 
 
 
none 
 
none 
 
Bacteria: 
F.n 
 
 
Control 
side 
 
 
 
25 
 
0.382 
(<104) 
 
 
0.51 (<106) 
 
bacterial increase 
(104 to 106) 
 
none 
 
Test side 
 
25 
 
0.51 (<106) 
 
0.508 (<106) 
 
none 
 
none 
 
Bacteria: 
C.r 
 
 
Control 
side 
 
 
 
25 
 
0.508 
(<106) 
 
 
0.382 (<104) 
 
bacterial decrease 
(106 to 104) 
 
none 
 
Test side 
 
25 
 
0.388 (<104) 
 
0.376 (<104) 
 
none 
 
none 
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Bacteria: 
E.n 
 
 
Control 
side 
 
 
 
25 
 
0.376 
(<104) 
 
 
0.362 (<104) 
 
 
 
none 
 
none 
 
Test side 
 
25 
 
0.36 (<104) 
 
0.364 (<104) 
 
none 
 
none 
 
Bacteria: 
E.c 
 
 
Control 
side 
 
 
 
25 
 
0.364 
(<104) 
 
 
0.376 (<104) 
 
 
 
none 
 
none 
 
Test side 
 
25 
 
0.39 (<104) 
 
0.394 (<104) 
 
none 
 
none 
 
Bacteria: 
C.s 
 
 
Control 
side 
 
 
 
25 
 
0.394 
(<104) 
 
 
0.36 (<104) 
 
 
 
none 
 
Yes 
 
 
 
Test side 
 
 
 
25 
 
0.364 
(<104) 
 
 
0.378 (<104) 
 
 
 
none 
 
none 
 
Value in () as per Micro IDent with “< , >” 
 
 
 
 
 
 
3.6.2. Statistical analysis 
 
 
Numbers were assigned to the bacterial collections and clinical parameters in order to 
maintain the anonymity of the patients. All the bacterial and clinical data was collected and 
inserted into an Excel spreadsheet (Excel 2012
®
, Microsoft1 Corp., Richmond, VA) and 
analysed with R Core Team (2013). R: A language and environment for statistical computing. 
R Foundation for Statistical Computing, Vienna, Austria. 
 
Each pair of quadrants (Q1 & Q4 and Q2 & Q3) were assessed as a “unit” for the bacterial 
collection and the clinical parameters for the statistical comparison. Group comparison of the 
clinical data for the groups of Q1 & Q4 and Q2 & Q3 were calculated. The means and 
standard 
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deviations were calculated from each clinical parameter that was recorded including the 
Micro-IDent
®
-11 PCR results, at the various periodontal sites and statistically analysed. The 
statistical analysis performed was based on a one-sample t-test. It was performed on the 
differences of the bacterial parameters before and after treatment. It was therefore essentially 
a paired t-test of the mean values. The degrees of freedom used for statistical analysis with 
the t-test was calculated as df=25-1=24. The statistical analysis of the data considered each of 
the bacterial species before and after treatment. In order to determine if the laser was an 
adjunct to conventional management made a statistical difference, the final analysis of the 
data was completed with the differences of differences (DID). The DID was obtained when 
the values considered for this test was calculated in the following mathematical equation: 
 
DID= Value before Conventional management with laser – Value after Conventional 
management with laser – (Value before Conventional management – Value after 
Conventional management). 
 
This test therefore calculated the final outcome of the average change in bacteria that 
occurred over time for the conventional management plus laser treatment (Test side) in 
relation to the conventional management alone (Control side) for the 25 patients. The data 
had to be interpreted based on the mathematical values in the equation to prevent a reverse 
casualty. A p-value of p< 0.05 was considered to be statistically significant (Gianelli, 2012). 
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Figure 11: Flow diagram of the statistical analysis of all the bacterial parameters and clinical 
parameters. 
 
 
 
 
 
3.7. ETHICAL CONSIDERATIONS: 
 
 
Ethical approval was required for this study and obtained (Reg no: 14/9/6). All the study 
participants signed a consent form after an information session regarding the study and 
recruitment was in accordance with good clinical practice. Numbers were assigned to the 
bacterial collections and clinical parameters in order to maintain the anonymity of the 
patients. 
 
The diode laser application was provided as an adjunct during the initial phase therapy, so the 
patient was not disadvantaged since, traditional clinically relevant periodontal management 
was still performed (namely scaling, root planing and polishing). There was no conflict of 
interest and no financial gain was applicable to the clinician should any discovery be made. 
The parameters of the laser utilised were safe according to the literature, therefore no damage 
or harm occurred to the patient nor any anatomical structures in the oral cavity. The operator 
and patient wore the approved personal protective equipment at all times during the operation 
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of the laser. If this study were to prove that the laser as an adjunct does have a significant 
beneficial effect, the laser application would then be performed on the quadrants previously 
treated with conventional management alone (Control side). 
 
 
 
 
 
3.8. POTENTIAL LIMITATIONS: 
 
 
Patient follow-up: 
 
 
The patients were followed up after 6 weeks. During the interval between visits patients were 
provided with detailed oral hygiene instructions and education. Patients were contacted once 
per week telephonically to motivate them to follow the oral hygiene instructions provided. 
 
Although the clinician provided the instructions, education and standardised tooth paste the 
patients may not have always explicitly followed these instructions, which could potentially 
influence the outcome of this study. 
 
 
 
 
This however did represent a real world scenario that clinicians are faced with in the clinical 
realm. This study was a split mouth randomized control trial thus the test and control sides 
would have been exposed to the same level of plaque control. This was confirmed by the 
plaque index reduction demonstrated in the both the test (320% reduction) and control sides 
(310% reduction). 
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CHAPTER 4: RESULTS AND DISCUSSION 
 
 
 
Terms utilized in this chapter 
 
 
 Conventional (periodontal) management: refers to scaling, root planing and polishing 
only. 
 Control quadrants: refers to study quadrants receiving conventional management 
only. 
 Test quadrants: refers to the study quadrants receiving conventional management and 
laser application as an adjunct. 
 
 
 
 
4.1. Randomised control trial design 
 
 
There were 25 participants in this split mouth randomised controlled trial. All the bacterial 
and clinical data was captured at the end of the study after the follow up of the 25th patient. 
 
The control and test sides were tabulated according to the left and right side distribution of 
the patients. This demonstrated a balanced distribution of the left and right sides to be either a 
control or test side. This favourable distribution was noted after data capturing (Table 6). 
 
 
 
Table 6: Randomisation of split mouth and side allocation 
 
 
  
Left side of 
participant 
 
 
 
Right side of participant 
 
Control side 
 
12 
 
13 
 
Test side 
 
13 
 
12 
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4.2. Statistical analysis of split mouth model 
 
 
 
4.2.1. Assessment of bacterial parameters for the split mouth model (before 
conventional management was performed): 
 
The distribution of the test and control sides were well balanced for this split mouth 
randomised control trial. Each patient served as his/her own control it and it was evaluated if 
there were significant differences in the bacterial count of the control and the test sides before 
conventional management. A paired t-test of the mean values was performed for each of the 
bacterial species that was collected at the first visit. 
 
Table 7 represented the difference in the mean value of the 25 patients for the bacterial 
collection before any treatment commenced. Significant difference between the left and the 
right side would be considered for a p<0.05. 
 
Table 7: Bacterial comparison for the left and right. 
 
 
Bacterial 
spp 
 
Mean 
difference in 
the Bacterial 
spp count (Left 
and Right) 
 
p-value 
 
A.a 
 
-0.01 
 
0.4863 
 
P.g 
 
0.00 
 
1 
 
T.f 
 
0.008 
 
0.6557 
 
T.d 
 
0.01 
 
0.3273 
 
P.i 
 
0.004 
 
0.7391 
 
P.m 
 
-0.008 
 
0.2943 
 
F.n 
 
0.00 
 
1 
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C.r 
 
-0.006 
 
0.6707 
 
E.n 
 
0.002 
 
0.6639 
 
E.c 
 
-0.014 
 
0.1479 
 
C.s 
 
-0.004 
 
0.6269 
 
 
 
 
 
The mean differences were demonstrated to be very small and close to zero (Table 7). The 
conclusion can therefore be drawn that there was no significant difference between the 
bacterial spp colonies present in the periodontal pockets of the left and right sides before 
conventional management. The split mouth model was therefore not biased with one side of 
the patient having a greater degree of bacterial colonization, compared to the opposite side. 
The evaluation of the side treated with the conventional management versus the conventional 
management plus the laser would therefore be comparable from a bacterial spp perspective 
(Table 7, Figure 12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Bacterial load of left and right side before treatment 
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4.2.2. Assessment of clinical parameters for the split mouth model – before 
conventional management performed: 
 
The distribution of the left and right sides were well balanced for the split mouth 
randomised control trial. Each patient served as his/her own control, therefore it was 
establish if there were significant differences in the clinical parameters of the left and the 
right sides. A paired t-test of the mean values was performed for each of the clinical 
parameters that were recorded at the first visit. 
 
Table 8 represents the difference in the mean value of the 25 patients for the clinical 
parameters before any conventional management was performed. Significant difference 
between the left and the right side would be considered for a p value of p<0.05. 
 
Table 8: Clinical parameter from the split mouth 
model 
 
 
Clinical 
parameter 
 
Mean 
difference in 
the clinical 
parameter (Left 
and Right) 
 
p-value 
 
PPD 
 
-0.0924 
 
0.3063 
 
REC 
 
0.1936 
 
0.2008 
 
CAL 
 
0.0896 
 
0.5992 
 
PI 
 
-0.2 
 
0.7505 
 
BOP 
 
-1.72 
 
0.4729 
 
 
 
PDD, PI and BOP indices were demonstrated to be higher on the right side, but there was 
no significant difference between the clinical parameters of the left and right sides before 
conventional management (Table 8, Figures 13, 14). The split mouth model was therefore 
not biased with one side of the patient having a significant difference in the clinical 
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parameters of periodontal disease. The evaluation of the side treated with the 
conventional management alone (Control side) versus the conventional management plus 
the laser (Test side) would therefore be comparable from a clinical perspective (Figures 
13, 14), as was noted with the bacterial spp parameters (Table 7, Figure 12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Graph depicting the PPD, REC, CAL parameters for the split mouth design. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Graph depicting the PI%, BOP% parameters for the split mouth design 
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4.3. Assessment of bacterial parameters 
 
 
4.3.1. Statistical analysis for the bacterial load of the before and after treatment 
 
 
The statistical analysis for the bacterial load for conventional management (before and after) 
as well as for the conventional management with the laser as adjunct (before and after) will 
be performed in a similar manner. The statistical analysis performed was based on a one- 
sample t-test. It was performed on the differences of the bacterial parameters before and after 
treatment. It was therefore essentially a paired t-test of the mean values. The statistical 
analysis of the data considered each of the bacterial species before and after treatment. 
Significant difference would be considered for a p-value of p<0.05. 
 
4.3.2. Bacterial parameters after conventional periodontal therapy (Control side). 
 
 
 
The effectiveness of conventional management on the bacterial load at visit one was 
compared to the bacterial load of the follow up visit 6 weeks later. 
 
Table 8 represents the difference in the mean value of the 25 patients for the bacterial 
collection after conventional management was performed on the control side. The mean was 
calculated by subtracting the initial bacterial spp load from the first visit (before conventional 
management commenced) from the bacterial collection at the second visit (follow up visit for 
bacterial collection after the conventional management of the first visit). 
 
 
Table 9: Bacterial load for conventional periodontal treatment (Control side) 
 
 
 
 
Bacterial load for conventional 
periodontal treatment (Control side) 
 
Bacterial 
spp 
 
Mean 
difference in 
the Bacterial 
spp count 
 
p-value 
 
A.a 
 
-0.014 
 
0.3557 
 
P.g 
 
0.02 
 
0.376 
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T.f 
 
0.016 
 
0.4838 
 
T.d 
 
0.06 
 
0.00157 
 
P.i 
 
0.032 
 
0.1148 
 
P.m 
 
0.028 
 
0.07963 
 
F.n 
 
-0.128 
 
5.008 
 
C.r 
 
0.126 
 
1.714 
 
E.n 
 
0.014 
 
0.1832 
 
E.c 
 
-0.012 
 
0.2071 
 
C.s 
 
0.034 
 
0.005254 
 
 
 
The conclusion from Table 9 illustrated that there was only a significant reduction in the 
bacterial colonies of T.d and C.s. This difference between the bacterial spp colonies for T.d 
and C.s had p-values of 0.00157 and 0.005254 respectively. A.a, F.n and E.c demonstrated an 
increase in the bacterial spp load after conventional management alone, although it did not 
have a p-value that was statistically significant (Table 9, Figure 15). 
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Figure 15: Bacterial load after conventional management (Control side) 
 
 
 
4.3.3. Bacterial parameters after conventional management plus laser treatment (Test 
side). 
 
The effectiveness of conventional management with the laser as an adjunct on the bacterial 
load at visit one (before any treatment) was compared to the bacterial load of the follow up 
visit 6 weeks later (after conventional management plus diode laser). 
 
Table 9 represents the difference in the mean value of the 25 patients for the bacterial 
collection after conventional management with the laser treatment was performed. The mean 
was calculated by subtracting the initial bacterial spp load from the first visit (before 
conventional management with laser) from the bacterial collection at the second visit (follow 
up visit for bacterial collection after the conventional management and laser therapy). 
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Table 10: Bacterial load for conventional management plus the laser (Test side) 
 
 
 
Conventional periodontal treatment plus 
laser (Test side) 
 
Bacterial 
spp 
 
Mean 
difference in 
the Bacterial 
spp count 
 
p-value 
 
A.a 
 
-0.008 
 
0.3563 
 
P.g 
 
0.028 
 
0.06961 
 
T.f 
 
0.012 
 
0.4907 
 
T.d 
 
-0.024 
 
0.1102 
 
P.i 
 
-0.006 
 
0.7045 
 
P.m 
 
-0.008 
 
0.4048 
 
F.n 
 
0.002 
 
0.8898 
 
C.r 
 
0.012 
 
0.2982 
 
E.n 
 
-0.004 
 
0.4907 
 
E.c 
 
-0.004 
 
0.6917 
 
C.s 
 
-0.014 
 
0.08968 
 
 
 
 
 
 
 
The conclusion from Table 9 demonstrated no significant reduction in the bacterial ssp. A 
slight increase was demonstrated in A.a, T.d, P.i, P.m, E.n, E.c, C.s bacterial spp load on the 
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test side, however this difference was not statistically significant. The remaining bacteria 
demonstrated a slight decrease, which was not statistically significant (Table 10, Figure 16). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Bacterial parameters after conventional management plus laser (Test side). 
 
 
 
4.3.4. Determining the effectiveness of the conventional plus laser (Test side) to the 
conventional management alone (Control side) for the bacterial parameters. 
 
The final analysis of the data was completed with the differences of differences (DID). The 
DID is obtained when the values considered for this test are calculated in the following 
mathematical equation: 
 
DID= Value before Conventional management with laser – Value after Conventional 
management with laser – (Value before Conventional management – Value after 
Conventional management). 
 
This test therefore calculated the final outcome of the average change in bacteria that 
occurred over time for the conventional  management plus laser treatment (Test side) in 
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relation to the conventional management alone (Control side) for the 25 patients. The data 
had to be interpreted based on the mathematical values in the equation to prevent a reverse 
casualty. This reverse casualty could occur, since the data is multi-dimensional data that was 
obtained over the course of the treatment. For example in the case of A.a. the DID p-value of 
0.7332 (Table 11) illustrates that for A.a there is no significant difference between laser as an 
adjunct, nor for conventional management alone for the reduction of A.a. Based on the 
individual p-values 0.3557 (A.a conventional management; Table 9) and 0.3563 (A.a laser as 
adjunct; Table 10) it can be calculated that these methodologies are equally in-effective in 
reducing A.a. The mean value -0.014 (A.a conventional management; Table 9) and -0.008 
(A.a laser as adjunct; Table 10) indicated a slight increase in A.a numbers, although not 
statistically significant. A significant difference between the control and the test side would 
be considered for a p<0.05. 
 
Table 11: The calculated DIDs for the conventional management plus laser (Test side) 
compared to conventional management alone (Control side). 
 
 
 
Conventional management plus laser 
(Test side) compared to Conventional 
management alone (Control side) 
 
Bacterial 
spp 
 
DID Mean 
 
p-value 
 
A.a 
 
0.006 
 
0.7332 
 
P.g 
 
0.008 
 
0.6716 
 
T.f 
 
-0.004 
 
0.8519 
 
T.d 
 
-0.084 
 
0.004216 
 
P.i 
 
-0.038 
 
0.2159 
 
P.m 
 
-0.036 
 
0.09816 
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F.n 
 
0.13 
 
3.235 
 
C.r 
 
-0.114 
 
6.663 
 
E.n 
 
-0.018 
 
0.185 
 
E.c 
 
0.008 
 
0.5573 
 
C.s 
 
-0.048 
 
0.00356 
 
 
 
 
 
 
 
The conclusion was that the laser as an adjunct to conventional management resulted in a 
statistically significant increase in the bacterial colonies of T.d and C.s (Table 11). The mean 
value 0.06 (T.d) (Red complex) and 0.034 (C.s) (Green complex) (conventional management 
alone); indicated a reduction in the bacterial load. For the laser adjunct side -0.024 (T.d) and - 
0.014 (C.s) (Table 10) represented an increase in the bacterial load when conventional 
management with laser as adjunct was performed (Table 9). 
 
With regards to the remaining red complex bacteria (P.g, T.f, P.i) no significant difference 
was found when using the diode laser as an adjunct to conventional management alone (Table 
11). 
 
4.4. Assessment of clinical parameters 
 
 
 
4.4.1. Statistical analysis for the clinical parameters before and after treatment 
 
 
The statistical analysis for the clinical parameters for conventional management alone 
(Control side) (before and after) as well as for the conventional management with the laser as 
an adjunct (Test side) (before and after) was performed in a similar manner. The statistical 
analysis performed was based on a one-sample t-test. It was performed on the differences of 
the clinical parameters before and after treatment. It was therefore essentially a paired t-test 
of the mean values. The statistical analysis of the data considered each of the clinical 
parameters before and after treatment. Significant difference would be considered for a p 
value of p<0.05. 
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4.4.2. Clinical parameters after conventional management alone (Control side) 
 
 
The effectiveness of conventional management alone on the clinical parameters at visit one 
was compared to the clinical parameters of the follow up visit 6 weeks later. 
 
Table 12 represents the difference in the mean value of the 25 patients for the clinical 
parameters after conventional management was performed. The mean was calculated by 
subtracting the initial clinical parameters from the first visit (before conventional 
management commenced) from the clinical parameters at the second visit (follow up visit for 
clinical parameters after the conventional management was performed). 
 
 
Table 12: Clinical parameters for conventional management alone (Control side) 
 
 
 
 
Clinical parameters for conventional 
periodontal treatment (Control side) 
 
clinical 
parameters 
 
Mean 
difference in 
the clinical 
parameters 
 
p-value 
 
PPD 
 
0.4644 
 
0.0002301 
 
REC 
 
0 
 
N/A 
 
CAL 
 
0.4648 
 
0.0002267 
 
PI 
 
48.4 
 
2.2 
 
BOP 
 
41.64 
 
8.038 
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Figure 17: Graph depicting the PPD, REC, CAL parameters before and after conventional 
management (Control side). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  18:  Graph  depicting  the  PI%,  BOP%  parameters  before  and  after  conventional 
management (Control side). 
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The conclusion from Table 12 was that there was only a statistically significant reduction in 
the clinical parameters for PPD and CAL. This difference between the clinical parameters for 
PPD and CAL had p-values of 0.0002301 and 0.0002267 respectively. 
 
The REC before conventional therapy and after had no difference at all and a mean and p- 
value could therefore be calculated The PI% and BOP% had a 310% and 240% reduction 
respectively, but no statistical p-values were obtained (Table 12, Figures 17, 18). 
 
 
 
 
4.4.3. Determining the effectiveness of the conventional management plus laser as 
adjunct (Test side) for the clinical parameters 
 
The effectiveness of conventional management with the laser as adjunct on the clinical 
parameters at visit one (before treatment) was compared to the clinical parameters of the 
follow up visit 6 weeks later. 
 
Table 13 represents the difference in the mean value of the 25 patients for the clinical 
parameters after conventional management with the laser as adjunct treatment was 
performed. The mean was calculated by subtracting the initial clinical parameters from the 
first visit (before conventional management with laser as adjunct) from the clinical 
parameters at the second visit (follow up visit for clinical parameters after the conventional 
management with laser as adjunct). 
 
 
Table 13: Clinical parameters for conventional management plus the laser (Test side). 
 
 
 
 
Conventional management plus laser 
(Test side) 
 
clinical 
parameters 
 
Mean 
difference in 
the clinical 
parameters 
 
p-value 
 
PPD 
 
0.4984 
 
3.852 
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REC 
 
0 
 
N/A 
 
CAL 
 
0.5288 
 
5.588 
 
PI 
 
49.4 
 
2.2 
 
BOP 
 
50.144 
 
1.302 
 
 
 
 
The data from Table 13 illustrated that the use of the laser as an adjunct to conventional 
management resulted in no significant reduction in any of the clinical parameters. The REC 
before conventional management and after had no difference at all and a mean and p-value 
could therefore not be calculated. The PI% and BOP% each had a 320% reduction, but no 
statistical p-values were obtained (Table 13, Figures 19, 20). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Graph depicting the PPD, REC, CAL parameters before and after conventional 
management plus laser (Test side) 
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Figure 20: Graph depicting the PI%, BOP% parameters before and after conventional 
management plus laser (Test side). 
 
4.4.4. Determining the effectiveness of the conventional management with laser as 
adjunct (Test side) compared to the conventional management alone (Test side) for the 
clinical parameters. 
 
The final analysis of the data was completed with the differences of differences (DID). The 
DID is obtained when the values considered for this test is calculated in the following 
mathematical equation: 
 
DID= Value before Conventional management with laser – Value after Conventional 
management with laser – (Value before Conventional management – Value after 
Conventional management). 
 
 
 
 
 
 
 
56  
Table 14: The calculated DIDs for the conventional management plus laser (Test 
side) compared to conventional management alone (Control side) 
 
 
 
Conventional management plus laser 
(Test side) compared to conventional 
management alone (Control side) 
 
clinical 
parameters 
 
DID Mean 
 
p-value 
 
PPD 
 
0.034 
 
0.7626 
 
REC 
 
0 
 
N/A 
 
CAL 
 
0.064 
 
0.586 
 
PI 
 
1 
 
0.2448 
 
BOP 
 
8.504 
 
0.005035 
 
 
The data from Table 14 illustrated that the test side (conventional management with laser 
as adjunct) compared to the control side (conventional management only) and no 
significant difference was found, with the exception of BOP% which was statistically 
significant p< 0.05 (Table 14) 
 
4.5. Patient distribution of Interleukin -1 
Genotype 
 
 
 
In this study the Interleukin-1 genotype was 
assessed. 
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Table 15: The patient distribution that presented with high and low risk IL-1 
genotype 
 
 
Total number of 
patients: 
 
 
 
Low risk: 
 
 
 
High risk: 
 
25 
 
18 
 
7 
 
 
Table 15 illustrated that the sample size of 25 patients was distributed as 7 High risk and 18 
Low risk I terleukin-1 genotypes. 
 
 
 
 
 
4.5.1. Bacterial parameters for the High vs Low risk 
Genotype 
 
 
A Welch two sample t-test of the mean values was performed for each of the bacterial species 
that was collected at the first visit. 
 
The difference in the mean values of the 18 low risk and 7 high risk genotype patients for the 
bacterial collection before any treatment commenced was assessed. Significant differences 
between genotype risks would be considered for a p<0.05. 
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Figure 21: Flowchart of Bacterial comparison for High vs Low risk Genotype 
 
 
 
 
 
 
Figure 22 illustrates the bacterial parameters at base line values of the first visit between the 
High and Low risk genotype patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: Bacterial parameters of High risk vs Low risk genotype at 
baseline 
 
A paired t-test of the mean values was performed for each of the bacterial species that 
was collected at the first visit. These mean values per bacterial species were compared for 
statistical significance between the high risk and low risk genotype. 
 
Table 16 represented the differences in the mean values of the 7 high risk and 18 low 
risk genotype patients for the bacterial collection before any treatment commenced. 
Significant difference between genotype risks would be considered for a p<0.05. 
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Table 16: Bacterial parameters at base line between High and Low genotype 
risk. 
 
 
 
 
 
Bacterial 
spp 
 
Mean 
difference in 
the Bacterial 
spp count (High 
and Low risk 
genotype) 
 
p-value 
 
A.a 
 
0.031 
 
0 
 
P.g 
 
0.03 
 
0.872 
 
T.f 
 
0.009 
 
1.0 
 
T.d 
 
-0.022 
 
0.247 
 
P.i 
 
-0.011 
 
0.346 
 
P.m 
 
-0.013 
 
0.305 
 
F.n 
 
0.016 
 
0 
 
C.r 
 
0.006 
 
0.595 
 
E.n 
 
-0.015 
 
0 
 
E.c 
 
-0.006 
 
0.393 
 
C.s 
 
-0.012 
 
0.289 
 
 
 
There were no significant differences in the mean values comparing the base line bacterial 
species parameters. The conclusion was that irrespective if the patient was determined to be 
of the High risk or Low risk genotype, at base line the differences in the bacterial parameters 
were not statistically significant. 
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4.5.2. Bacterial parameters of Control and Test sides after 
treatment 
 
 
Table 17 represented the differences between the mean values per genotype and control 
or test sides, to establish if there were statistical significances after treatment. 
 
Table 17: Bacterial comparison for High vs Low risk Genotype 
 
 
 
Bacterial 
spp 
 
Mean 
difference 
in the 
Bacterial 
spp count 
(High) 
Control 
 
Mean 
difference 
in the 
Bacterial 
spp count 
(Low) 
Control 
 
p- 
value 
 
Mean 
difference 
in the 
Bacterial 
spp count 
(High) 
Test 
 
Mean 
difference 
in the 
Bacterial 
spp count 
(Low) 
Test 
 
p- 
value 
 
Mean 
difference 
in the 
Bacterial 
spp count 
(High) 
DID 
 
Mean 
difference 
in the 
Bacterial 
spp count 
(Low) 
DID 
 
p- 
value 
 
A.a 
 
-0.007 
 
-0.016 
 
0.833 
 
0.014 
 
-0.016 
 
0.157 
 
2.142 
 
3.081 
 
0.709 
 
P.g 
 
0.071 
 
0 
 
0.192 
 
0.042 
 
0.022 
 
0.561 
 
-0.028 
 
0.022 
 
0.398 
 
T.f 
 
0.092 
 
-0.013 
 
0.024 
 
0.021 
 
0.008 
 
0.708 
 
-0.071 
 
0.022 
 
0.099 
 
T.d 
 
0.028 
 
0.072 
 
0.214 
 
-0.028 
 
-0.022 
 
0.813 
 
-0.057 
 
-0.094 
 
0.438 
 
P.i 
 
0.014 
 
0.038 
 
0.607 
 
-0.028 
 
0.002 
 
0.3 
 
-0.042 
 
-0.036 
 
0.917 
 
P.m 
 
0.042 
 
0.022 
 
0.476 
 
-0.014 
 
-0.005 
 
0.583 
 
-0.057 
 
-0.027 
 
0.424 
 
F.n 
 
-0.157 
 
-0.116 
 
0.335 
 
0.035 
 
-0.011 
 
0.316 
 
0.192 
 
0.105 
 
0.272 
 
C.r 
 
0.092 
 
0.138 
 
0.111 
 
0.035 
 
0.002 
 
0.28 
 
-0.057 
 
-0.136 
 
0.113 
 
E.n 
 
0.014 
 
0.013 
 
0.981 
 
-0.007 
 
-0.002 
 
0.678 
 
-0.021 
 
-0.016 
 
0.838 
 
E.c 
 
-0.007 
 
-0.013 
 
0.708 
 
0.007 
 
-0.008 
 
0.41 
 
0.014 
 
0.005 
 
0.708 
 
C.s 
 
0.035 
 
0.033 
 
0.918 
 
-0.021 
 
-0.011 
 
0.624 
 
-0.1 
 
0.07 
 
0.75 
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T.f. demonstrated a statistical significant difference in the mean values of the High and 
the Low risk genotype patients in the control group.  This p-value indicated the statistical 
significant difference between these mean values p=0.024. The overall DID effect of the 
laser as an adjunct in the High and the Low risk genotypes was not statistically significant. 
 
 
4.5.3. Clinical parameters for the High vs Low risk Genotype 
 
 
 
A Welch two sample t-test of the mean values was performed for each of the clinical 
parameters that was collected at the first visit. 
 
The difference in the mean values of the 7 High risk and 18 Low risk genotype patients for 
the clinical parameters before any treatment commenced was assessed. Significant difference 
between genotype risks would be considered for a p<0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Flowchart of Clinical parameters comparison for High vs Low risk Genotype 
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A paired t-test of the mean values was performed for each of the clinical parameters that were 
collected at the first visit. These mean values of the clinical parameters were compared for 
statistical significance between High risk and Low risk genotype. 
 
 
Table 18: Clinical parameters for High vs Low risk genotype at base line 
 
 
 
 
Clinical parameters for High vs Low risk 
genotype at base line 
 
clinical 
parameters 
 
Mean 
difference in 
the mean 
clinical 
parameters 
 
p-value 
 
PPD 
 
0.344 
 
1 
 
REC 
 
0.467 
 
0.757 
 
CAL 
 
0.796 
 
0.866 
 
PI 
 
2.098 
 
0.567 
 
BOP 
 
-2.298 
 
0.430 
 
 
 
 
 
 
Figures 24, 25 illustrated the clinical parameters at base line values of the first visit between 
the 7 High and 18 Low risk genotype patients indicated no difference at all. Although the 
standard deviation differed between High and Low risk genotypes the mean values were the 
same. Therefore there was no statistical differences could be calculated for the 7 High risk 
compared to the 18 Low risk patients. 
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Figure 24: Graph depicting the PPD, REC, CAL parameters for the High and Low risk 
genotype 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: Graph depicting the PI%, BOP% parameters for the High and Low risk genotype 
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Table 19 represents the differences between the mean values per genotype and control or test 
sides, to establish if there were statistical significance after treatment for the clinical 
parameters. 
 
Table 19: Clinical parameters for High vs Low risk Genotype 
 
 
 
 
Clinical 
parameter 
 
Mean 
difference 
in the 
Clinical 
parameter 
count 
(High) 
Control 
 
Mean 
difference 
in the 
Clinical 
parameter 
count 
(Low) 
Control 
 
p- 
value 
 
Mean 
difference 
in the 
Clinical 
parameter 
count 
(High) 
Test 
 
Mean 
difference 
in the 
Clinical 
parameter 
count 
(Low) 
Test 
 
p- 
value 
 
Mean 
difference 
in the 
Clinical 
parameter 
count 
(High) 
DID 
 
Mean 
difference 
in the 
Clinical 
parameter 
count 
(Low) 
DID 
 
p- 
value 
 
PPD 
 
0.32 
 
0.52 
 
0.241 
 
0.588 
 
0.463 
 
0.451 
 
0.268 
 
-0.057 
 
0.072 
 
REC 
 
0 
 
0 
 
NA 
 
0 
 
0 
 
NA 
 
0 
 
0 
 
NA 
 
CAL 
 
0.32 
 
0.521 
 
0.239 
 
0.578 
 
0.509 
 
0.685 
 
0.258 
 
-0.011 
 
0.148 
 
PI 
 
47.571 
 
48.722 
 
0.842 
 
45.714 
 
50.833 
 
0.264 
 
-1.857 
 
2.111 
 
0.057 
 
BOP 
 
38.428 
 
42.888 
 
0.5 
 
48.428 
 
50.811 
 
0.817 
 
10 
 
7.922 
 
0.791 
 
 
 
 
 
 
 
 
 
There was no statistical significance for any clinical parameter between the high and low risk 
genotypes for the control or test sides. There was also no DID significance for the use of the 
laser as an adjunct on the high and low risk genotype patients. 
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4.6. DISCUSSION: 
 
 
 
4.6.1. Split mouth study design: 
 
 
The results of the split mouth comparison in this study, demonstrated that the split mouth 
study design was a viable methodology to compare changes in the bacterial load and clinical 
parameters. The results demonstrated no significant difference between the bacterial spp load 
present in the periodontal pockets of the left and right sides before any treatment was 
performed. 
 
The clinical parameters (namely PDD, PI and BOP indices) were demonstrated to be slightly 
higher on the right side, but there was no significant difference between the clinical 
parameters of the left and right sides before any treatment was performed. The split mouth 
model was therefore not biased with one side of the patient having a significant difference in 
the clinical parameters of periodontal disease, compared to the other side. 
 
 
 
 
 
4.6.2. Bacterial and clinical parameters: 
 
 
In a review by Cobb (2010) on lasers as an adjunct, marked differences within study 
methodologies where found, making direct comparisons between pre-operative and post- 
operative treatment parameters difficult. Despite the study heterogeneity, this study’s 
findings and conclusion were similar. 
 
 
 
 
 
4.6.2.1. Bacterial parameters: 
 
 
Two of the reviewed studies assessed improvement in bacterial load with the diode laser as 
an adjunct to conventional treatment (Moritz,  1997. Alves,  2013) (Table 1). The reviewed 
studies used techniques such as bacterial culturing and the counting of colony forming 
units (CFU), to assess these changes in the bacterial load. These studies revealed 
improvements in bacterial load in periodontal pockets, however these results were also not 
statistically significant for the diode laser as an adjunct (Moritz,  1997. Alves,  2013). 
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This study utilised PCR to assess the changes in bacterial load. The control side demonstrated 
only a significant reduction in the bacterial colonies of T.d and C.s. A slight increase in the 
bacterial spp load of A.a, F.n and E.c was demonstrated on the control side, however this 
increase was not statistically significant. 
 
The test side demonstrated no significant reduction in the bacterial ssp. A slight increase was 
demonstrated in A.a, T.d, P.i, P.m, E.n, E.c, C.s bacterial spp load on the test side, however 
this difference was not statistically significant. The remaining bacteria demonstrated a slight 
reduction, which was not statistically significant. 
 
Further analysis (DID) was performed to determine the effectiveness of the laser as an 
adjunct when comparing the control side to the test side for the bacterial parameters. This 
study demonstrated that the laser as an adjunct resulted in statistically significant increases in 
the bacterial colonies of T.d and C.s. With regards to the remaining red complex bacteria 
(P.g, T.f,) no significant difference was found when comparing the laser as an adjunct to 
conventional management alone. 
 
A recent study (Hajishengallis, 2011) has demonstrated that even when present in low 
numbers P.g. plays a significant role in altering the composition of the biofilm. P.g. can be 
considered as a “keystone pathogen” as it directs the genetic response of the other organisms 
(Hajishengallis, 2011). The fact that the diode laser as an adjunct did not significantly have 
an impact on the levels of P.g. in this thesis, can be hypothesized as a possible reason for 
failure of the laser to cause significant reductions in the bacterial parameters. 
 
The true effect of the diode laser alone on periodontal pathogens on a cellular and molecular 
level has not been established. The potential structural changes that could occur in the 
periodontal pathogens (i.e. cell wall destruction, bacterial virulence reduction, decreased 
colony forming ability etc.) could be an essential component to establish the true effect of the 
laser. 
 
Harris (2004) assessed the effect of the 810nm diode laser on the periodontal pathogen 
 
P.g on blood agar. The hypothesis was that the blood agar represented the periodontal 
pocket, since the haemoglobin will absorb the laser energy in a similar manner as the 
periodontal pocket. The conclusion was that the 810nm laser results in ablation of both P.g 
and the agar (Harris,  2004). Therefore the true ablation capacity of the diode laser for 
P.g could be masked by the haemoglobin absorption and the resulting cumulative absorption 
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in the periodontal pocket. This could explain the significant decrease in BOP with the laser as 
an adjunct. Although P.g. was not statistically decreased, the inflamed pocket that contains 
the haemoglobin chromophores absorbed the laser energy, resulting in the removal of the 
inflamed tissue. 
 
 
 
 
 
4.6.2.2. Clinical parameters: 
 
 
Three studies assessed improvement in clinical parameters (Kriesler 2005. Zingale, 2012. 
Alves, 2013). Alves (2013) found no difference in clinical parameters between the test and 
control sides for the CAL, PI, PPD and BOP. No significant differences were found for 
CAL, PPD and BOP (Zingale, 2012). Only one of these studies demonstrated a statistical 
significant change in clinical parameters (PPD; CAL) with the diode laser as an adjunct to 
conventional management (Kriesler,  2005). However, Kriesler (2005) demonstrated no 
statistical difference for PI, GI, BOP. 
 
In this study the control side demonstrated reductions in BOP %, however the results were 
not statistically significant. The control side demonstrated a statistically significant reduction 
in the clinical parameters for PPD and CAL. The test side demonstrated reductions BOP % 
was not statistically significant. The test side demonstrated no significant reduction in any 
other clinical parameters. 
 
Further analysis was performed to determine the effectiveness control side compared to the 
test side for the clinical parameters. This data was completed with the DID formula. The 
results demonstrated no significant difference between the test and control sides for 
improvement in clinical parameters, with exception of BOP% which demonstrated significant 
improvement on the test side compared to control side. 
 
An essential difference in this thesis was that the bacterial collection, clinical parameter 
assessment and treatment was performed at the first visit. Thus the patient had no prior 
knowledge of the study and could therefore not perform an elevated level of oral hygiene 
practices before the first visit. Moritz (1997) performed the base line bacterial collection at 
beginning of week 2, after one conventional management appointment had already been 
performed.  Kriesler (2005) performed laser  treatment  after  two  visits  of  conventional
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periodontal treatment. Alves (2012) collected the bacterial and clinical parameters at the 
beginning of week 2, after four preceding conventional management appointments. 
 
Kriesler (2005) and Alves (2013) performed a randomised split mouth study. Although lasing 
and conventional management timelines differed they were the closest in study design to this 
thesis. The question that however becomes apparent when considering the study designs of 
Kriesler (2005) and Alves (2013): “Is it the laser that results in the clinical and 
bacterial parameters changing, or simply the multiple conventional management visits that 
were performed?”. The continuous disruption of the biofilm in the studies of Kriesler 
(2005) and Alves (2013) could have brought about the changes in clinical parameters 
observed. Studies have demonstrated that disruption of the bacterial biofilm is 
paramount to the effective management of periodontitis (Kinane, 2005). 
 
The result from Moritz (1997) and Alves (2013) for the bacterial parameters tested was 
similar to this thesis with no significant difference in the bacterial parameters demonstrated in 
the laser test groups (P.i, P.g, A.a) (Cobb, 2010. Alves, 2013). 
 
 
 
 
 
4.6.3. Interleukin-1 genotype and its association with bacterial and clinical parameters: 
 
 
This study also assessed the possible impact of a high risk Interleukin-1 genotype on baseline 
clinical and bacterial parameters, as well as treatment outcomes. 
 
Based on the results there is no significant difference between the high versus low risk patient 
genotypes when comparing baseline bacterial and clinical parameters. The data demonstrates 
that irrespective of the patient’s genotype (High or Low risk), the laser had no significant 
impact on the bacterial parameters nor the clinical parameters as an adjunct. 
 
Socransky (2000) performed a study to assess the association with between the interleukin -
1 genotype and the bacterial parameters. The study sample was divided into groups 
based on the periodontal pocket depth. This study demonstrated that pockets <4mm and 
pockets between 4-6mm had statistically less red and complex bacteria, compared to 
pockets ≥ 6mm. in those individuals with a high risk interleukin -1 genotype, the bacterial 
parameters (red and orange complex) were significantly higher in pockets of ≥ 6mm. 
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In this study the mean PPD at baseline was 3.7 (±0.61) mm. Based on the findings of 
Socransky (2000) it is plausible that due to the lower mean PPD values in this study, no 
significant association was thus demonstrated between the high risk genotype and the 
bacterial parameters. 
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CHAPTER 5: CONCLUSION AND RECOMMENDATIONS 
 
 
The review of the literature identified four studies (Table 1) which evaluated the diode laser 
as an adjunct in the management of chronic periodontitis. The conclusion that can be drawn 
from these studies was that the diode laser as an adjunct provided very little bacterial or 
clinical benefit to the patient. 
 
The American Academy of Periodontology (2011) stated that the use of lasers as an adjunct 
to non-surgical periodontal therapy has no beneficial effect. 
 
A systematic review by Cheng (2016) came to the conclusion that no full consensus on the 
efficacy of adjunctive laser therapy has been reached. No beneficial effect of the diode 
laser as an adjunct compared to the conventional management has been demonstrated for the 
laser used at various treatment intervals, due to inappropriate study designs and the limited 
number of studies that had assessed the clinical effects of adjunctive laser therapy (Cheng, 
2016). 
 
This thesis demonstrated that the use of the diode laser (810nm) as an adjunct at the initial 
visit provided no benefit for the clinical parameters, with the exception of a significant 
improvement in BOP%. The diode laser as an adjunct also did not have a significant effect on 
the reduction of bacterial load of the red complex bacteria (P.g, T.f,) with the exception of 
T.d. that demonstrated a statistical increase. None of the other bacteria assessed (A.a, P.m, 
F.n, C.r, E.n, E.c) demonstrated a significant reduction, with the exception of C.s which 
also demonstrated a statistically significant increase. 
 
It can be concluded that within the limitations of this study, that the utilization of the diode 
laser (810 ± 10nm) as an adjunct at the initial visit had no statistical effect in the reduction of 
the bacterial parameters nor resulted in an overall improvement of the clinical parameters. 
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Recommendations: 
 
 
Further laboratory studies (such as live cell studies under confocal microscopy) are required 
to assess the true effect of the diode laser (810 ±10 nm) on the bacterial biofilm and 
periodontal tissues. Only upon establishment of the effect of the diode laser on the biofilm, 
could clinical recommendations be made for the correct power, wave length settings and 
frequency of laser application. Longitudinal studies are required to evaluate the long-term 
post therapeutic effect of the diode laser (810 ±10 nm) on clinical and bacterial parameters. 
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APPENDICES 
 
 
 
Consent form 
 
 
University of the Western Cape (UWC) 
 
 
 
 
Dear Patient …………………….. (place patient sticker) 
 
 
 
Dr. Sune Mulder – van Staden is performing research on “the use of a diode laser in the 
treatment of periodontitis”. In order to conduct this research, the laser will be used in addition 
to scaling, root planing and polishing on one side of your mouth. Patient confidentiality will 
be preserved. 
 
 
By signing this form you grant permission for: 
 
- the taking of  xrays ( pantomograph and periapicals ) 
 
- the taking of clinical photographs 
 
- the assessment of the current periodontal status 
 
- treatment of periodontitis by means of scaling, root planing and polishing 
 
- the application of the diode laser on one side of the mouth 
 
- the results of the study can be used for publication, without revealing patient identity 
 
 
If this study were to prove that the laser does have a significant beneficial effect, the laser 
treatment will then be performed on the quadrants previously treated with conventional 
management alone. 
 
 
 
 
Signature: …………………………………….. Date: ……………………… 
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